BioCorRx Forms Subsidiary For Abuse-Deterrent Drug Development
By
BioCorRx Inc., an addiction-treatment company and developer of the BioCorRx Recovery Program, a medication-assisted treatment program, has formed a new subsidiary, BioCorRx Pharmaceuticals, in conjunction with the company’s development, commercialization…
Sunovion to Acquire Cynapsus Therapeutics
By
Sunovion Pharmaceuticals, a biopharmaceutical company headquartered in Marlborough, Massachusetts, has agreed to acquire Cynapsus Therapeutics, a Toronto-based specialty central nervous system pharmaceutical company focused on Parkinson’s disease, for $40.50 per…